During the past decade, Marienhospital Stuttgart conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marienhospital Stuttgart" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "AIO-Studien-gGmbH" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marienhospital Stuttgart" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator and "German CLL Study Group" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Marienhospital Stuttgart" are "Chronic Lymphocytic Leukemia" (5 trials), "Ovarian Cancer" (2 trials), "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Marienhospital Stuttgart" in a lesser frequency.

Most popular intervention types in "Marienhospital Stuttgart" are "Drug" (15 trials), "Biological" (6 trials), "Other" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (4 trials), "Venetoclax" (4 trials), "Fludarabine" (3 trials), "Carboplatin" (2 trials) and "Chlorambucil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Marienhospital Stuttgart" are 18 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Marienhospital Stuttgart". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Marienhospital Stuttgart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marienhospital Stuttgart, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Marienhospital Stuttgart has several departments that took part in Clinical trials: "Marienhospital Stuttgart, Dpt. of Anaesthesiology" - 2 trials